The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BOPA/ISOPP 2019 | ISOPP 2019 reviews ESMO: data highlights
Dharmisha Chauhan, MPharm, The Royal Marsden NHS Foundation Trust, London, UK, lists the data highlights from ESMO 2019, including the BEACON CRC trial (NCT02928224), updates in the melanoma and sarcoma fields, and new renal cancer guidelines.This interview took place at the International Society of Oncology Pharmacy Practitioners (ISOPP) Symposium 2019, hosted by the British Oncology Pharmacy Association (BOPA), held in London, UK.
